Literature DB >> 6305369

The release of leukotriene B4 during experimental inflammation.

P M Simmons, J A Salmon, S Moncada.   

Abstract

Leukotriene B4 (LTB4) has been detected by radioimmunoassay in inflammatory exudates obtained following the implantation of saline- or carrageenan-soaked polyester sponges in rats. The immunoreactive material was confirmed as LTB4 after extraction and purification by high pressure liquid chromatography. The peak concentration (6.9 +/- 0.5 ng/ml) was detected 6 hr after implantation of sponges soaked in 0.5% carrageenan; thereafter the level declined and was undetectable after 16-24 hr. The concentration of LTB4 during the early phase of the inflammatory response (4-8 hr) is sufficient to induce leukocyte aggregation, chemotaxis and degranulation of polymorphonuclear leukocytes (PMN) in vitro. Therefore, LTB4 may mediate, at least in part, the influx of PMN and contribute to other events which characterise the inflammatory response. The level of thromboxane B2 (TXB2) in the inflammatory exudate followed a similar time-course to that of LTB4 although the maximum concentration was higher (15-30 ng/ml). However, prostaglandin E2 (PGE2) exhibited a different time-course; the maximum level (20-30 ng/ml) was also reached 6-8 hr after implantation but remained elevated at 24 hr. The PMN count in the sponges and the concentrations of both LTB4 and TXB2, but not PGE2, were significantly reduced by prior treatment of the animals with colchicine. This suggests that PMN are the major source of LTB4 and TXB2 in the inflammatory exudate whereas PGE2 is produced in significant amounts by other tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305369     DOI: 10.1016/0006-2952(83)90446-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

1.  Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.

Authors:  D J Meyers; R S Berk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.

Authors:  M J DiMartino; D E Griswold; B A Berkowitz; G Poste; N Hanna
Journal:  Agents Actions       Date:  1987-02

3.  Characterization of a polyacrylamide gel-induced granuloma in mice: involvement of arachidonate metabolites.

Authors:  M Errasfa; F Russo-Marie
Journal:  Agents Actions       Date:  1988-06

4.  Synthesis of eicosanoids by tissues of the synovial joint during the development of chronic erosive synovitis.

Authors:  B Henderson; G A Higgs; S Moncada; J A Salmon
Journal:  Agents Actions       Date:  1986-01

5.  Leukotriene B4 induces enhanced migration of fish leucocytes in vitro.

Authors:  T C Hunt; A F Rowley
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

6.  Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.

Authors:  E Moilanen; J Alanko; A Juhakoski; H Vapaatalo
Journal:  Agents Actions       Date:  1989-08

7.  Eicosanoid production in rheumatoid synovitis.

Authors:  E Moilanen; J Alanko; M Nissilä; M Hämäläinen; H Isomäki; H Vapaatalo
Journal:  Agents Actions       Date:  1989-11

8.  In vitro effects of leukotriene B4 (LTB4) on canine PMN effector function(s).

Authors:  D F Gruber; M M D'Alesandro; T L Walden
Journal:  Agents Actions       Date:  1989-11

9.  Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C.

Authors:  G A Higgs; K G Mugridge; S Moncada; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  The mechanism of the anti-inflammatory effect of turpentine in the rat.

Authors:  J Damas; E Deflandre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.